Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.
Drug Development
Reports
Displaying 21 - 30 of 34. 10 per page. Page 3.
Advanced SearchContinuation of Drug Risk Adjustment
Prepared by: National Opinion Research Center (NORC) at the University of Chicago Prepared for:U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
Compendium of Home Modification and Assistive Technology Policy and Practice Across States: Final Report
U.S. Department of Health and Human Services
Evaluation of New Measures of Assistive Technology and the Home Environment from the 2005 Pilot Study of Technology and Aging
U.S. Department of Health and Human Services
Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report
U.S. Department of Health and Human Services Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report Part I. Recommended Modules and Instrument Development Process
Impact of Policies to Limit Drug Plan's Financial Risk
This paper examines the combined effects of drug plan risk the first year of Medicare part D implementation of the combination of reinsurance, risk-adjustment and risk-corridors
Issues in the Design and Implementation of Drug Formularies and Therapeutic Classes
As part of the Medicare Part D pharmacy benefit scheduled for implementation in 2006 by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), beneficiaries will have a choice of private plans administering the benefit.? Although plans are required to provide access to needed drugs, the law does not require plans to provide equal coverage for all drugs.?
Barriers to Implementing Technology in Residential Long-Term Care Settings
U.S. Department of Health and Human Services